Finding studies
Finding studies
Take this into the appointment.
Saves the questions and what to expect into your notes, next to the visit they belong to.
Lead
biotx.ai GmbH
The study will include hospitalized, moderate COVID-19 cases that have a risk of respiratory failure. The study will generally consist of: * A short screening phase (1 day) before enrollment and thus treatment decision. * A 21 day treatment phase with one "cycle" of palbociclib * An up to day 90 Safety Follow-Up Phase The first three patients will be enrolled and treated one by one; the independent safety data review committee (ISRC) will review each patient after D21 before enrollment of the subsequent patient is permitted.
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
